Evidence map›Paper›PMID 41600803›Full record

ReviewViruses2025

The Forgotten History of Bacteriophages in Bulgaria: An Overview and Molecular Perspective on Their Role in Addressing Antibiotic Resistance and Therapy.

Nikolay Kalvatchev, Tannaz Khanbabapour, Arit Sakkeer, Iliya Tsekov, Yancho Delchev, Tanya Strateva

Abstract readReviewHistorical Article
In one paragraph

Review in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nikolay KalvatchevDepartment of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.
Tannaz KhanbabapourFaculty of Medicine (Foreign Students), Medical University of Sofia, 1431 Sofia, Bulgaria.
Arit SakkeerFaculty of Medicine (Foreign Students), Medical University of Sofia, 1431 Sofia, Bulgaria.
Iliya TsekovVirology Laboratory, Nadezhda Women's Health Hospital, 1330 Sofia, Bulgaria.
Yancho DelchevClinic of General and Oncological Gynecology, Military Medical Academy, 1606 Sofia, Bulgaria.
Tanya StratevaDepartment of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.ORCID 0000-0002-5197-1849

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages, often referred to as "bacteria eaters," have gained renewed interest as a powerful alternative to traditional antibiotics, particularly in addressing antibiotic-resistant bacterial infections. The present review summarizes data collected in Bulgaria during the 1960s, 1970s, and 1980s, drawing connections between past findings and present-day understanding of cytotoxicity and the clinical validation of bacteriophage applications. Its sections describe phage structure, mechanisms of action, and historical findings both globally and within the Bulgarian context, while also highlighting emerging trends and applications. The cited studies delve into the past through contemporary research contributions related to "Bulgarian phages", a topic that remains underexplored in existing literature. The role of phages in medical microbiology is discussed alongside the challenges of therapeutic implementation, with particular focus on insights gained from the Bulgarian experience. In conclusion, by fostering international collaborations, investing in infrastructure, and establishing supportive policies, bacteriophage therapy can emerge as a critical tool for managing bacterial infections and reducing the global burden of antibiotic resistance in the future.

Indexed as

Bacterial InfectionsBacteriophagesDrug Resistance, BacterialPhage TherapyAnti-Bacterial AgentsBacteriaBulgariaHistory, 20th CenturyHistory, 21st CenturyHumansAnti-Bacterial Agentsantibiotic resistanceBacteriophagesBulgariacytotoxicitylytic activity

Identifiers

PMID41600803
PMCPMC12846619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.